Tuesday 4 November 2025
Home      All news      Contact us      RSS     
Stony Brook - 3 years ago

Stony Brook Enters Licensing Deal to Bring Anti-Cancer Technology to Market

Stony Brook University has entered into a licensing agreement with a startup company, CadheRx Therapeutics, to develop and market an anti-cancer technology discovered by Sabine Brouxhon, MD, Clinical Associate Professor in the Department of Emergency Medicine at Stony Brook University School of Medicine. The technology involves use of an antibody-based cancer therapy that down-regulates a plethora of pathways associated with resistant disease. The approach could advance treatment for patients with many forms of cancer, including breast, colorectal, lung, skin, and other epithelial-derived cancers.


Latest News
Hashtags:   

Stony

 | 

Brook

 | 

Enters

 | 

Licensing

 | 

Bring

 | 

Cancer

 | 

Technology

 | 

Market

 | 

Sources